John Marioni (via Wellcome Sanger Institute)

April 28, 2022 08:30 AM EDTUpdated May 2, 04:31 PM

Aviv Regev recruits a ‘purple unicorn’ for the top post in the computational pillar she’s building at Genentech

Two years after Aviv Regev left her scientific abode at the Broad and journeyed west to take over as the new head of research and …

Endpoints Premium

This article is available only to Premium subscribers

Upgrade to Premium for unlimited access and Premium exclusives.

UPGRADE LOG IN

ENDPOINTS CAREERS

COO / Head of Operations (Stealth Portfolio Company)‬ ‭

Autonomy Bio Inc.

San Francisco, CA 94107, USA

view job offer post your job now

TRENDING NOW

Why Regeneron is buying 23andMe

David Liu, Sam Sternberg unveil new way to insert big genes in human cells

Regeneron plans to buy 23andMe for $256M

Intellia's CRISPR therapy likely causes 'permanent' gene knockdown in ATTR amyloidosis

Prime Medicine sidelines only clinical program, replaces CEO and lays off some staff

sponsored

Does your supply chain hold up under pressure for high-risk temperature-critical shipments?